Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.1K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

892
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
892

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multisite Chronic Pain Reveals Neuro-Immune-Metabolic Dysregulation across Rheumatoid Arthritis and Depression.

Research (Washington, D.C.)·2026
Same author

Widespread use of invalid statistical tests in biomedical machine learning.

bioRxiv : the preprint server for biology·2026
Same author

Exploring fMRI-neurofeedback to reduce craving-related brain activity in people with cannabis use disorder: A feasibility study.

Addictive behaviors·2026
Same author

From whole-body to organ-specific biological age clocks.

Nature aging·2026
Same author

Sleep chart of biological ageing clocks in middle and late life.

Nature·2026
Same author

Biochemical and brain heterogeneity characterizes psychiatric and non-psychiatric illness.

Nature communications·2026

Related Experiment Video

Updated: Mar 15, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

8.0K

Abnormal white matter integrity in synthetic cannabinoid users.

Nabi Zorlu1, Maria Angelique Di Biase2, Çiğdem Çolak Kalaycı1

  • 1Department of Psychiatry, Katip Celebi University, Ataturk Training and Research Hospital, Izmir, Turkey.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|September 13, 2016
PubMed
Summary

Synthetic cannabinoid use significantly alters brain structure in young adults, causing white matter abnormalities. This may lead to cognitive deficits and increased psychosis risk.

Keywords:
DTISynthetic cannabinoidsWhite matter

More Related Videos

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

877
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

631

Related Experiment Videos

Last Updated: Mar 15, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

8.0K
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

877
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

631

Area of Science:

  • Neuroscience
  • Toxicology
  • Radiology

Background:

  • Synthetic cannabinoids are increasingly prevalent, particularly among adolescents and young adults.
  • The impact of synthetic cannabinoid use on human brain structure remains largely unexamined.
  • Understanding these effects is critical due to rising usage rates.

Purpose of the Study:

  • To investigate the structural brain changes associated with long-term synthetic cannabinoid consumption.
  • To assess potential correlations between synthetic cannabinoid use and white matter integrity.

Main Methods:

  • Diffusion Tensor Imaging (DTI) was employed to examine brain structure.
  • The study included 22 long-term synthetic cannabinoid users and 18 healthy controls.
  • Analysis focused on fractional anisotropy (FA) to measure white matter integrity.

Main Results:

  • Significantly reduced fractional anisotropy (FA) was observed in synthetic cannabinoid users compared to controls.
  • Affected white matter regions included the left temporal lobe, subcortical structures, and brainstem.
  • Key white matter tracts affected were the inferior fronto-occipital fasciculus, inferior longitudinal fasciculus, fornix, cingulum-hippocampus, and corticospinal tracts.

Conclusions:

  • Long-term synthetic cannabinoid use is linked to white matter abnormalities in adolescents and young adults.
  • Compromised brain connectivity in users may contribute to cognitive impairment.
  • These abnormalities could increase vulnerability to psychosis.